Physician

David Allen Hotchkiss, M.D.

According to 2025 Medicare claims, David Hotchkiss, M.D. (NPI: 1548377435) practices cardiology in the Punta Gorda, FL market, with the plurality of this provider's patient population coming from Charlotte, FL. This provider's primary affiliated billing organization is PEACE RIVER CARDIOVASCULAR CENTER (NPI: 1326553793; TIN: 82-3450771) and primary practice location at 33952-9283. Hotchkiss is affiliated with the CHSPSC ACO 6, LLC (ACO ID: A3712), participating under the MSSP model.

Hotchkiss' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,519 traditional Medicare patients, billed 9,113 HCPCS/CPT codes, and received $571,147 in Medicare payments. The top billing code was 78452 (Nuclear medicine studies of heart muscle at rest and with stress and spect). Part D data shows 10,208 prescription claims across 1,480 beneficiaries totaling $2,550,094 in drug costs, led by Eliquis (Apixaban). 2017 DME data shows 12 claims. Open Payments data shows 80 records totaling $1,041,559. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $1,032,928 to $571,147. In contrast, Part D prescription costs have moved sharply higher in recent years, from $710,464 to $2,550,094. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,355	18,252	$1,032,928
2016	2,217	17,646	$1,060,229
2017	2,118	18,516	$1,066,560
2018	1,992	16,237	$1,024,730
2019	1,805	17,354	$1,095,804
2020	1,801	13,580	$975,332
2021	1,881	11,468	$924,728
2022	1,679	9,457	$737,744
2023	1,716	11,599	$831,399
2024	1,519	9,113	$571,147

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	868	6,597	$710,464
2016	918	6,664	$851,686
2017	953	6,540	$880,539
2018	997	6,358	$920,136
2019	1,151	7,765	$1,253,831
2020	1,229	8,581	$1,614,486
2021	1,359	9,201	$1,971,225
2022	1,379	9,536	$2,296,034
2023	1,439	9,417	$2,402,244
2024	1,480	10,208	$2,550,094

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	23	$48,783
2016	N/R	N/R	N/R
2017	N/R	12	$25,826
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78452	Nuclear medicine studies of heart muscle at rest and with stress and spect	199	199	$324
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	427	446	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	979	1,242	$89
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	202	203	$49
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	1,135	1,331	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	994	66,160	$1,257,016
Entresto	Sacubitril/Valsartan	247	16,969	$372,798
Xarelto	Rivaroxaban	267	20,577	$369,593
Multaq	Dronedarone Hcl	135	7,180	$184,491
Repatha Sureclick	Evolocumab	77	4,918	$94,105

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	42	$1,246	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	38	$1,040,313	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Allen Hotchkiss, M.D.?

Tedicare shows public-source Medicare data for David Allen Hotchkiss, M.D. (NPI 1548377435), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Allen Hotchkiss, M.D. have ACO affiliation data?

David Allen Hotchkiss, M.D. is shown with ACO affiliation data for CHSPSC ACO 6, LLC (MSSP, ACO ID A3712).

What billing organization is linked to David Allen Hotchkiss, M.D.?

David Allen Hotchkiss, M.D. is linked to PEACE RIVER CARDIOVASCULAR CENTER (billing NPI 1326553793) in the available physician profile data.

Does David Allen Hotchkiss, M.D. have Open Payments data?

David Allen Hotchkiss, M.D. has 80 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.